ArticleCancer gene therapy2022

Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation.

Yu-Hsuan Fu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.